A detailed history of Two Sigma Investments, LP transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 34,423 shares of AURA stock, worth $282,268. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,423
Previous 86,283 60.1%
Holding current value
$282,268
Previous $652,000 53.07%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.9 - $10.36 $357,834 - $537,269
-51,860 Reduced 60.1%
34,423 $306,000
Q2 2024

Aug 14, 2024

SELL
$6.81 - $7.89 $187,996 - $217,811
-27,606 Reduced 24.24%
86,283 $652,000
Q1 2024

May 15, 2024

BUY
$7.09 - $9.24 $506,949 - $660,678
71,502 Added 168.69%
113,889 $894,000
Q4 2023

Feb 14, 2024

BUY
$7.02 - $11.98 $297,556 - $507,796
42,387 New
42,387 $375,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $240M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.